300511 Stock Overview
Engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shanghai Xuerong Biotechnology Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.43 |
| 52 Week High | CN¥4.79 |
| 52 Week Low | CN¥2.40 |
| Beta | 0.20 |
| 1 Month Change | 3.31% |
| 3 Month Change | -23.44% |
| 1 Year Change | 3.63% |
| 3 Year Change | -52.16% |
| 5 Year Change | -58.87% |
| Change since IPO | -59.64% |
Recent News & Updates
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Not Doing Enough For Some Investors As Its Shares Slump 26%
Jan 06
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Shares Fly 48% But Investors Aren't Buying For Growth
Oct 08Recent updates
Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Not Doing Enough For Some Investors As Its Shares Slump 26%
Jan 06Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) Shares Fly 48% But Investors Aren't Buying For Growth
Oct 08Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Price Is Right But Growth Is Lacking After Shares Rocket 45%
Aug 19Little Excitement Around Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Revenues As Shares Take 31% Pounding
Jun 27There's No Escaping Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Muted Revenues Despite A 25% Share Price Rise
May 13Shanghai Xuerong Biotechnology Co.,Ltd.'s (SZSE:300511) Shares Bounce 25% But Its Business Still Trails The Industry
Mar 15Shareholder Returns
| 300511 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 2.4% | -1.3% | 0.02% |
| 1Y | 3.6% | 2.5% | 18.1% |
Return vs Industry: 300511 exceeded the CN Food industry which returned 2.5% over the past year.
Return vs Market: 300511 underperformed the CN Market which returned 18.1% over the past year.
Price Volatility
| 300511 volatility | |
|---|---|
| 300511 Average Weekly Movement | 6.9% |
| Food Industry Average Movement | 6.2% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 300511 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300511's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 2,513 | Yongping Yang | www.xuerong.com |
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, industrial planting, and sale of fresh edible mushrooms in the People’s Republic of China. It offers shiitake, shiji, king oyster, velvet, antler, and shiitake mushrooms, as well as Pleurotus eryngii and Flammulina velutipes. The company was formerly known as Shanghai Gaorong Food Co., Ltd.
Shanghai Xuerong Biotechnology Co.,Ltd. Fundamentals Summary
| 300511 fundamental statistics | |
|---|---|
| Market cap | CN¥1.69b |
| Earnings (TTM) | -CN¥223.86m |
| Revenue (TTM) | CN¥2.26b |
0.8x
P/S Ratio-7.6x
P/E RatioIs 300511 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300511 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.26b |
| Cost of Revenue | CN¥2.28b |
| Gross Profit | -CN¥14.73m |
| Other Expenses | CN¥209.12m |
| Earnings | -CN¥223.86m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 28, 2025
| Earnings per share (EPS) | -0.45 |
| Gross Margin | -0.65% |
| Net Profit Margin | -9.89% |
| Debt/Equity Ratio | 180.9% |
How did 300511 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 09:21 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Xuerong Biotechnology Co.,Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jia Chen | Changjiang Securities Co. LTD. |
| You You Liu | China Stock Investment Research Co. Ltd. (GZ500..com) |
| Xiao Bao Liu | Everbright Securities Co. Ltd. |